Skip to main content
Sign In

Kristen Zhelnin, MD

Assistant Professor

  • BA in Biology: Washington University in St. Louis (2007)
  • MD: Medical College of Georgia (2011)

Postdoctoral Education:
  • Anatomic and Clinical Pathology Residency, University of Colorado (2015)
  • Gastrointestinal/Liver Pathology Fellowship, Emory University (2016)

Board Certifications:
  • Anatomic and Clinical Pathology (2015)

Professional Experience:
  • Gastrointestinal Pathologist, Peak Gastroenterology Associates (2016-2017)
  • Pathologist, Memorial Hospital (2017)

  • Voss K, Bollag R, Fussell N, By C, Sheehan D, Bollag W. Aquaporin 3 and Phospholipase D2 Expression in Basal and Squamous Cell Carcinoma [abstract]. J Invest Dermatol. 2009 Apr;129(1 Suppl):S32 abstract 187. 
  • Voss KE, Bollag RJ, Fussell N, By C, Sheehan DJ, Bollag WB. Abnormal aquaporin-3 protein expression in hyperproliferative skin disorders. Arch Dermatol Res. 2011 Oct;303(8):591-600. 
  • Mattei J, Kim FJ, Phillips JM, Zhelnin KE, Said S, Sehrt D, Molina WR. Male Primary Retroperitoneal Mucinous Cystadenoma. Urology. 2013 Jul;82(1):e1-e2. 
  • Halenda KM, Kudchadkar RR, Lawson DH, Kies DD, Zhelnin KE, Krasinskas AM, Gossniklaus HE. Reduction of nodular growth pattern of metastatic uveal melanoma after radioembolization of hepatic metastases. Ocul Oncol Pathol 2016;2:160–165. 
  • Zhelnin K, Gebhard B, Mirsky D, Oliver S, Lovell MA, Galambos C, Crombleholme T, McCourt E. Pediatric intraocular immature teratoma associated with sacrococcygeal teratoma: case report and review of the literature. Pediatr Dev Pathol. 2017 Jun;20(3):240-244. 
  • Zhelnin K, Xue Y, Quigley B, Reid M, Choi H, Memis B, Adsay V, Krasinskas A. Non-mucinous Epithelium is a Common Finding in Mucinous Cystic Neoplasms of the Pancreas and Liver. Am J Surg Pathol. 2017 Jan;41(1):116-120. 
  • ​Lopez-Aguiar AG, Ethun CG, Postlewait LM, Zhelnin K, Krasinskas A, El-Rayes BF, Russell MC, Sarmiento JM, Kooby DA, Staley CA, Maithel SK, Cardona K. Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors: Improving Its Prognostic Value for Recurrence of Disease. Ann Surg Oncol. 2018 Jan;25(1):290-298.